SIRT1 and metabolic disease: As an example, lack of SIRT1-, SIRT2-, and SIRT6-dependent deacetylation and activation of specific adipose gene programs was shown to contribute to the development of metabolic disorders, such as type 2 diabetes and obesity [81].